Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 16, 2020 SAM #6804
SOLICITATION NOTICE

66 -- nCounter MAX Analysis System NCT-SYST-200

Notice Date

7/14/2020 9:23:10 AM
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

NOI-NIAID-2031995
 

Response Due

7/21/2020 2:00:00 PM
 

Archive Date

08/05/2020
 

Point of Contact

Dana Monroe, Phone: 4063759814
 

E-Mail Address

dana.monroe@nih.gov
(dana.monroe@nih.gov)
 

Description

PRE-SOLICITATION NOTICE NOI-NIAID-2031995 NAICS � 334516 This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Nanostring Technologies to procure a Nanostring nCounter MAX Analysis System NCT-SYST-200 based on a trade-in of a Nanostring nCounter Sprint System and initial 18 months of service. For the past 5 years, the Translational Autoinflammatory Disease Studies (TADS) unit within NIH/NIAID has been measuring the presence of an interferon (IFN) gene signature in patients with undifferentiated or with well-defined autoinflammatory diseases. They have developed an IFN score using a customized Nanostring gene panel for the detection of an IFN signature. Thus far they have checked more than 2000 RNA samples and observed a high specificity and reproducibility of the Nansotring assay for the detection of an IFN signature. The Nanostring technology is based on the principles of nucleotide hybridization and digital counting, which enables quantitative measurement of up to 800 transcripts in one reaction and significantly decrease the cost as compared to RT-qPCR. Therefore, it is critical to be able to utilize this technology given the age of the patients involved in this study (children) and the limited availability of samples. Using the Nanostring nCounter System the TADS unit has been able to identify which transcripts are increased or decreased in whole blood RNA of patients with autoinflammatory diseases before and after treatment, which also helps to determine the efficacy of therapy. It is critical and imperative to the future of the studies to maintain the consistency of the Nanostring nCounter Systems.� This update to the MAX Analysis System is crucial to advances in field. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2031995 to Dana Monroe at dana.monroe@nih.gov by Tuesday, July 21, 2020, 5:00pm eastern daylight savings time.� All responses received by the closing date of this synopsis will be considered by the Government.� A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/28e6c3861ce644a7903918c31f9e7d3d/view)
 

Place of Performance

Address: Bethesda, MD 20892, USA

Zip Code: 20892

Country: USA
 

Record

SN05720890-F 20200716/200714230200 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |